Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shao-Ai Cai"'
Autor:
Shao-Ai Cai, Ning Hou, Gan-Jian Zhao, Xia-Wen Liu, Ying-Yan He, Hai-Lin Liu, Yong-Quan Hua, Li-Rong Li, Yin Huang, Cai-Wen Ou, Cheng-Feng Luo, Min-Sheng Chen
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Puerarin is an isoflavone isolated from Radix puerariae. Emerging evidence shown that puerarin possesses therapeutic benefits that aid in the prevention of cardiovascular diseases. In this study, we evaluated the effects of puerarin on oxidative stre
Externí odkaz:
https://doaj.org/article/798ccd0b477a419a9ff8b564f97a4a2e
Autor:
Ning Hou, Wenchang Yuan, Xia-Wen Liu, Xiaohui Chen, Dao-feng Cai, Xiaoxia Qiu, Li-Rong Li, Shiming Liu, Cheng-Feng Luo, Minsheng Chen, Jing-xuan Xie, Chuanfang Cheng, Gan-Jian Zhao, Yin Huang, Shao-Ai Cai, Ai-qun Li
Publikováno v:
Acta Pharmacol Sin
Estrogen deficiency induces cardiac dysfunction and increases the risk of cardiovascular disease in postmenopausal women and in those who underwent bilateral oophorectomy. Previous evidence suggests that puerarin, a phytoestrogen, exerts beneficial e
Autor:
Li-Rong Li, Xia-Wen Liu, Ning Hou, Wei-Biao Pan, Gan-Jian Zhao, Yong-Ying Shi, Shao-Ai Cai, Cheng-Feng Luo, Hao-Xin Zhan, Wenchang Yuan, Yin Huang
Publikováno v:
The Journal of pharmacy and pharmacology. 73(12)
Objectives Investigate if azilsartan protects against myocardial hypertrophy by upregulating nuclear factor erythroid 2-related factor 2 (Nrf2)-mediated pathways. Methods Abdominal aortic constriction (AAC)-induced cardiac hypertrophy in rats was app
Autor:
Hailin Liu, Xiuli Zhang, Xinglong Zhong, Caiwen Ou, Zehua Li, Shao-Ai Cai, Minsheng Chen, Pingzhen Yang
Publikováno v:
European journal of pharmacology. 855
The risk of cardiovascular events in patients with chronic kidney disease is tremendously increased due to vascular calcification. Local vascular inflammation significantly promotes vascular calcification. A previous study has shown that puerarin inh
Autor:
Zhen-Yu Xiong, Gan-Jian Zhao, Aiqun Li, Xiaohui Chen, Chuanfang Cheng, Caiwen Ou, Shiming Liu, Yun-Pei Mai, Yin Huang, Li-Rong Li, Cheng-Feng Luo, Ning Hou, Shao-Ai Cai, Xia-Wen Liu, Minsheng Chen
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 366(3)
Previous evidence has suggested that puerarin may attenuate cardiac hypertrophy; however, the potential mechanisms have not been determined. Moreover, the use of puerarin is limited by severe adverse events, including intravascular hemolysis. This st